2021 多学科实践指南:嗜铬细胞瘤和副神经节瘤的诊断、遗传咨询和治疗

2021-05-06 国外肿瘤科相关专家小组(统称) Clin Transl Oncol.2021 May 6.

嗜铬细胞瘤和副神经节瘤 (PPGLs) 是罕见的神经内分泌肿瘤,本文旨在从多角度为PPGLs的诊断和治疗提供使用的临床指南。

中文标题:

2021 多学科实践指南:嗜铬细胞瘤和副神经节瘤的诊断、遗传咨询和治疗

英文标题:

Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas

发布日期:

2021-05-06

简要介绍:

嗜铬细胞瘤和副神经节瘤 (PPGLs) 是罕见的神经内分泌肿瘤,本文旨在从多角度为PPGLs的诊断和治疗提供使用的临床指南。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 多学科实践指南:嗜铬细胞瘤和副神经节瘤的诊断、遗传咨询和治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=233561c0021013b2, title=2021 多学科实践指南:嗜铬细胞瘤和副神经节瘤的诊断、遗传咨询和治疗, enTitle=Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas, guiderFrom=Clin Transl Oncol.2021 May 6., authorId=0, author=, summary=嗜铬细胞瘤和副神经节瘤 (PPGLs) 是罕见的神经内分泌肿瘤,本文旨在从多角度为PPGLs的诊断和治疗提供使用的临床指南。, cover=https://img.medsci.cn/2021518/1621305305181_2020535.jpg, journalId=0, articlesId=null, associationId=887, associationName=国外肿瘤科相关专家小组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Thu May 06 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>嗜铬细胞瘤和副神经节瘤 (PPGLs) 是罕见的神经内分泌肿瘤,本文旨在从多角度为PPGLs的诊断和治疗提供使用的临床指南。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=11634, tagName=嗜铬细胞瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=26, categoryName=泌尿外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=11634, guiderKeyword=嗜铬细胞瘤, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=9381, appHits=243, showAppHits=0, pcHits=851, showPcHits=9136, likes=0, shares=16, comments=6, approvalStatus=1, publishedTime=Tue May 18 10:40:22 CST 2021, publishedTimeString=2021-05-06, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue May 18 10:35:13 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 06:05:12 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 多学科实践指南:嗜铬细胞瘤和副神经节瘤的诊断、遗传咨询和治疗.pdf)])
2021 多学科实践指南:嗜铬细胞瘤和副神经节瘤的诊断、遗传咨询和治疗.pdf
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=968285, encodeId=fa9296828516, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd4b5484443, createdName=ms6000000660506060, createdTime=Mon May 24 23:43:16 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203483, encodeId=6a5d120348387, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200910/eda6ba2bf5774add938300ca63aeafbd/29e55ac72962479d9204d7b410393e35.jpg, createdBy=f7c31458860, createdName=june_ly, createdTime=Thu Mar 17 15:56:12 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185048, encodeId=c69d118504874, content=thanks, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52e6469572, createdName=ms3000000757148214, createdTime=Mon Jan 17 05:52:11 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967404, encodeId=761f96e40448, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3d65505521, createdName=ms5000000859249015, createdTime=Fri May 21 09:57:03 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967331, encodeId=1ed096e331c0, content=好指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905505382, createdName=ms8000000769818805, createdTime=Thu May 20 22:17:06 CST 2021, time=2021-05-20, status=1, ipAttribution=)]
    2021-05-24 ms6000000660506060

    学习了

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=968285, encodeId=fa9296828516, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd4b5484443, createdName=ms6000000660506060, createdTime=Mon May 24 23:43:16 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203483, encodeId=6a5d120348387, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200910/eda6ba2bf5774add938300ca63aeafbd/29e55ac72962479d9204d7b410393e35.jpg, createdBy=f7c31458860, createdName=june_ly, createdTime=Thu Mar 17 15:56:12 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185048, encodeId=c69d118504874, content=thanks, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52e6469572, createdName=ms3000000757148214, createdTime=Mon Jan 17 05:52:11 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967404, encodeId=761f96e40448, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3d65505521, createdName=ms5000000859249015, createdTime=Fri May 21 09:57:03 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967331, encodeId=1ed096e331c0, content=好指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905505382, createdName=ms8000000769818805, createdTime=Thu May 20 22:17:06 CST 2021, time=2021-05-20, status=1, ipAttribution=)]
    2022-03-17 june_ly

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=968285, encodeId=fa9296828516, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd4b5484443, createdName=ms6000000660506060, createdTime=Mon May 24 23:43:16 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203483, encodeId=6a5d120348387, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200910/eda6ba2bf5774add938300ca63aeafbd/29e55ac72962479d9204d7b410393e35.jpg, createdBy=f7c31458860, createdName=june_ly, createdTime=Thu Mar 17 15:56:12 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185048, encodeId=c69d118504874, content=thanks, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52e6469572, createdName=ms3000000757148214, createdTime=Mon Jan 17 05:52:11 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967404, encodeId=761f96e40448, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3d65505521, createdName=ms5000000859249015, createdTime=Fri May 21 09:57:03 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967331, encodeId=1ed096e331c0, content=好指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905505382, createdName=ms8000000769818805, createdTime=Thu May 20 22:17:06 CST 2021, time=2021-05-20, status=1, ipAttribution=)]
    2022-01-17 ms3000000757148214

    thanks

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=968285, encodeId=fa9296828516, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd4b5484443, createdName=ms6000000660506060, createdTime=Mon May 24 23:43:16 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203483, encodeId=6a5d120348387, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200910/eda6ba2bf5774add938300ca63aeafbd/29e55ac72962479d9204d7b410393e35.jpg, createdBy=f7c31458860, createdName=june_ly, createdTime=Thu Mar 17 15:56:12 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185048, encodeId=c69d118504874, content=thanks, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52e6469572, createdName=ms3000000757148214, createdTime=Mon Jan 17 05:52:11 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967404, encodeId=761f96e40448, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3d65505521, createdName=ms5000000859249015, createdTime=Fri May 21 09:57:03 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967331, encodeId=1ed096e331c0, content=好指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905505382, createdName=ms8000000769818805, createdTime=Thu May 20 22:17:06 CST 2021, time=2021-05-20, status=1, ipAttribution=)]
    2021-05-21 ms5000000859249015

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=968285, encodeId=fa9296828516, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd4b5484443, createdName=ms6000000660506060, createdTime=Mon May 24 23:43:16 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203483, encodeId=6a5d120348387, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200910/eda6ba2bf5774add938300ca63aeafbd/29e55ac72962479d9204d7b410393e35.jpg, createdBy=f7c31458860, createdName=june_ly, createdTime=Thu Mar 17 15:56:12 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185048, encodeId=c69d118504874, content=thanks, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52e6469572, createdName=ms3000000757148214, createdTime=Mon Jan 17 05:52:11 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967404, encodeId=761f96e40448, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e3d65505521, createdName=ms5000000859249015, createdTime=Fri May 21 09:57:03 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967331, encodeId=1ed096e331c0, content=好指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905505382, createdName=ms8000000769818805, createdTime=Thu May 20 22:17:06 CST 2021, time=2021-05-20, status=1, ipAttribution=)]
    2021-05-20 ms8000000769818805

    好指南

    0

拓展阅读

嗜铬细胞瘤和副神经节瘤诊断治疗的专家共识

中华医学会内分泌学分会(CSE,Chinese Society of Endocrinology) · 2016-04-02

2020 ESMO/EURACAN临床实践指南:肾上腺皮质癌和恶性嗜铬细胞瘤的诊断,治疗以及随访

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2020-08-24

嗜铬细胞瘤和副神经节瘤诊断治疗专家共识(2020版)

中华医学会内分泌学分会(CSE,Chinese Society of Endocrinology) · 2020-09-30

2021 国际共识:无症状SDHx基因突变携带者的初始筛查和随访

国外肿瘤科相关专家小组(统称) · 2021-05-21

《嗜铬细胞瘤和副神经节瘤诊断治疗专家共识(2020版)》解读

福建医科大学附属第一医院全科医学科福建省高血压研究所 · 2021-08-15